Krishnan Aravind, Ruaengsri Chawannuch, Guenthart Brandon A, Shudo Yasuhiro, Wang Hanjay, Ma Michael R, MacArthur John Ward, Hiesinger William, Woo Y Joseph
Department of Cardiothoracic Surgery, Stanford University School of Medicine, Stanford, California.
Department of Bioengineering, Stanford University School of Engineering, Stanford, California.
JAMA Netw Open. 2024 Mar 4;7(3):e241828. doi: 10.1001/jamanetworkopen.2024.1828.
The use of ex vivo normothermic organ perfusion has enabled the use of deceased after circulatory death (DCD) donors for heart transplants. However, compared with conventional brain death donation, DCD heart transplantation performed with ex vivo organ perfusion involves an additional period of warm and cold ischemia, exposing the allograft to multiple bouts of ischemia reperfusion injury and may contribute to the high rates of extracorporeal membrane oxygenation usage after DCD heart transplantation.
To assess whether the beating heart method of DCD heart transplantation is safe and whether it has an acceptable rate of extracorporeal membrane oxygenation use postoperatively.
DESIGN, SETTING, AND PARTICIPANTS: This case series includes 10 patients with end-stage heart failure undergoing DCD heart transplantation at a single academic medical center from October 1, 2022, to August 3, 2023. Data were analyzed from October 2022 to August 2023.
Using a beating heart method of implantation of the donor allograft.
The main outcome was primary graft dysfunction necessitating postoperative initiation of mechanical circulatory support. Survival and initiation of mechanical circulatory support were secondary outcomes.
In this case series, 10 consecutive patients underwent DCD heart transplantation via the beating heart method. Ten of 10 recipients were male (100%), the mean (SD) age was 51.2 (13.8) years, and 7 (70%) had idiopathic dilated cardiomyopathy. Ten patients (100%) survived, and 0 patients had initiation of extracorporeal membrane oxygenation postoperatively. No other mechanical circulatory support, including intra-aortic balloon pump, was initiated postoperatively. Graft survival was 100% (10 of 10 patients), and, at the time of publication, no patients have been listed for retransplantation.
In this study of 10 patients undergoing heart transplantation, the beating heart implantation method for DCD heart transplantation was safe and may mitigate ischemia reperfusion injury, which may lead to lower rates of primary graft dysfunction necessitating extracorporeal membrane oxygenation. These results are relevant to institutions using DCD donors for heart transplantation.
使用体外常温器官灌注使得心脏移植能够使用循环死亡后捐赠者(DCD)。然而,与传统脑死亡捐赠相比,采用体外器官灌注进行的DCD心脏移植涉及额外的一段温缺血和冷缺血时间,使同种异体移植物暴露于多次缺血再灌注损伤,这可能是DCD心脏移植后体外膜肺氧合使用率高的原因之一。
评估DCD心脏移植的跳动心脏法是否安全,以及术后体外膜肺氧合的使用率是否可接受。
设计、地点和参与者:本病例系列包括2022年10月1日至2023年8月3日在一家学术医疗中心接受DCD心脏移植的10例终末期心力衰竭患者。数据于2022年10月至2023年8月进行分析。
采用供体同种异体移植物的跳动心脏植入法。
主要结局是需要术后启动机械循环支持的原发性移植物功能障碍。生存和启动机械循环支持是次要结局。
在本病例系列中,10例连续患者通过跳动心脏法接受了DCD心脏移植。10名受者均为男性(100%),平均(标准差)年龄为51.2(13.8)岁,7例(70%)患有特发性扩张型心肌病。10例患者(100%)存活,0例患者术后启动体外膜肺氧合。术后未启动包括主动脉内球囊泵在内的其他机械循环支持。移植物存活率为100%(10例患者中的10例),在发表时,没有患者被列入再次移植名单。
在这项对10例接受心脏移植患者的研究中,DCD心脏移植的跳动心脏植入法是安全的,可能减轻缺血再灌注损伤,这可能导致需要体外膜肺氧合的原发性移植物功能障碍发生率降低。这些结果与使用DCD供体进行心脏移植的机构相关。